Status and phase
Conditions
Treatments
About
Induce tolerance or reduce the amount of immunosuppression after renal transplant patient (receiving cadaver kidney)with so called TAIZ-monocytes
Sex
Ages
Volunteers
Inclusion and exclusion criteria
4.3.1 Inclusion Criteria
Patients must meet all the following inclusion criteria to be considered for admission to the trial:
Male or female adult patients aged between 18 and 64 years (inclusive). A female of childbearing potential may be enrolled provided she:
Patients receiving a first renal transplant.
Patients who fulfil the criteria to receive an allogeneic renal transplant from a cadaver (according to the Eurotransplant (ET) manual on organ allocation and the Bundesärztekammer allocation criteria).
Patients who, after the nature of the study and the disclosure of their data has been explained to them, have freely given Informed Consent in writing.
4.3.2 Exclusion Criteria
Patients presenting any of the following exclusion criteria must not be included in the trial:
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal